OR WAIT null SECS
© 2022 MJH Life Sciences and Consultant Live. All rights reserved.
June 14, 2021
Carl Regillo, MD and Diana Do, MD react to newer therapies being explored for wet AMD and discuss their place in future therapeutic algorithms.
June 07, 2021
An overview of new gene therapy options for wet AMD that are currently being explored in clinical trials.
Results of recent phase III clinical trials with respect to efficacy and safety of faricimab, an investigational bispecific antibody which inhibits both VEGF-A and angiopoietin-2.
June 01, 2021
Retina specialists provide insight into the patient selection and safety concerns with the innovative Port Delivery System (PDS) that offers a new means of sustained anti-VEGF therapy.